Kamada Ltd SEC filings KMDA

Kamada Ltd has 538 filings in SEC EDGAR's recent list, going back to Jan 24, 2013. Its latest annual report, Form 20-F, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Mar 11, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Mar 5, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Mar 6, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Mar 15, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 15, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Feb 24, 2021 Dec 31, 2020
20-F/A Amended annual report (foreign issuer) Mar 16, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Feb 26, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Feb 27, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 6, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Mar 1, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Feb 25, 2016 Dec 31, 2015
20-F Annual report (foreign issuer) Apr 28, 2015 Dec 31, 2014
20-F Annual report (foreign issuer) Mar 26, 2014 Dec 31, 2013

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KMDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Rehovot, Israel
SEC filer status
Accelerated filer
SEC CIK
1567529

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.